The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment

被引:234
作者
Gracie, Dowd J. [1 ]
Hamlin, P. John [1 ]
Ford, Alexander C. [1 ,2 ]
机构
[1] Leeds Teaching Hosp Natl Hlth Serv Trust, St Jamess Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Med Res St Jamess, Leeds, W Yorkshire, England
关键词
QUALITY-OF-LIFE; FECAL MICROBIOTA TRANSPLANTATION; BIFIDOBACTERIUM-LONGUM NCC3001; C-REACTIVE PROTEIN; IBS-LIKE SYMPTOMS; ULCERATIVE-COLITIS; CROHNS-DISEASE; PERCEIVED STRESS; DOUBLE-BLIND; PSYCHOLOGICAL COMORBIDITY;
D O I
10.1016/S2468-1253(19)30089-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Brain-gut interactions affect psychological wellbeing and symptom reporting in functional gastrointestinal disorders; the presence of anxiety or depression is associated with the development of new-onset gastrointestinal symptoms, and the presence of gastrointestinal symptoms is associated with the development of psychological disorders de novo. In inflammatory bowel diseases (IBD), the reporting of irritable bowel syndrome (IBS)-type symptoms by patients with quiescent disease is common, and is associated with psychological disorders, impaired quality of life, and increased health-care use. In IBD, data from observational studies suggest that psychological disorders might be associated with relapse of disease activity, and that inflammatory activity is associated with the development of new psychological disorders, as has been described for functional gastrointestinal disorders such as IBS and functional dyspepsia. The brain-gut axis provides the physiological link between the CNS and gastrointestinal tract that might facilitate these relationships. In IBS, treatments targeting disordered brain-gut axis activity, including psychological therapies and antidepressants, might lead to improved symptoms and quality of life. However in IBD, the benefit of these treatments is less certain because of a scarcity of interventional studies. Despite the scarcity of trials, observational data suggest that the effect of disordered brain-gut axis activity in IBD is substantial, and scope remains for further well designed trials of psychological therapies and antidepressants, particularly in the subset of patients who have coexistent psychological disorders, or in those who report IBS-type symptoms. Integrating these treatments into a biopsychosocial model of care has the potential to improve both psychological wellbeing and quality of life in some patients with IBD, reducing healthcare use and altering the natural history of disease.
引用
收藏
页码:632 / 642
页数:11
相关论文
共 106 条
[1]   Systematic review with meta-analysis: the impact of a depressive state on disease course in adult inflammatory bowel disease [J].
Alexakis, C. ;
Kumar, S. ;
Saxena, S. ;
Pollok, R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (03) :225-235
[2]   The Intestinal Microenvironment and Functional Gastrointestinal Disorders [J].
Barbara, Giovanni ;
Feinle-Bisset, Christine ;
Ghoshal, Uday C. ;
Santos, Javier ;
Vanner, Stepen J. ;
Vergnolle, Nathalie ;
Zoetendal, Erwin G. ;
Quigley, Eamonn M. .
GASTROENTEROLOGY, 2016, 150 (06) :1305-+
[3]   Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study [J].
Beaugerie, Laurent ;
Brousse, Nicole ;
Bouvier, Anne Marie ;
Colombel, Jean Frederic ;
Lemann, Marc ;
Cosnes, Jacques ;
Hebuterne, Xavier ;
Cortot, Antoine ;
Bouhnik, Yoram ;
Gendre, Jean Pierre ;
Simon, Tabassome ;
Maynadie, Marc ;
Hermine, Olivier ;
Faivre, Jean ;
Carrat, Fabrice .
LANCET, 2009, 374 (9701) :1617-1625
[4]   The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication [J].
Bercik, P. ;
Park, A. J. ;
Sinclair, D. ;
Khoshdel, A. ;
Lu, J. ;
Huang, X. ;
Deng, Y. ;
Blennerhassett, P. A. ;
Fahnestock, M. ;
Moine, D. ;
Berger, B. ;
Huizinga, J. D. ;
Kunze, W. ;
McLean, P. G. ;
Bergonzelli, G. E. ;
Collins, S. M. ;
Verdu, E. F. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 (12) :1132-E544
[5]   Chronic Gastrointestinal Inflammation Induces Anxiety-Like Behavior and Alters Central Nervous System Biochemistry in Mice [J].
Bercik, Premysl ;
Verdu, Elena F. ;
Foster, Jane A. ;
Macri, Joseph ;
Potter, Murray ;
Huang, Xiaxing ;
Malinowski, Paul ;
Jackson, Wendy ;
Blennerhassett, Patricia ;
Neufeld, Karen A. ;
Lu, Jun ;
Khan, Waliul I. ;
Corthesy-Theulaz, Irene ;
Cherbut, Christine ;
Bergonzelli, Gabriela E. ;
Collins, Stephen M. .
GASTROENTEROLOGY, 2010, 139 (06) :2102-U409
[6]  
Berding Anja, 2017, Inflamm Intest Dis, V1, P182, DOI 10.1159/000452989
[7]   Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels [J].
Berrill, James W. ;
Sadlier, Mike ;
Hood, Kerenza ;
Green, John T. .
JOURNAL OF CROHNS & COLITIS, 2014, 8 (09) :945-955
[8]   Psychosocial determinants of relapse in ulcerative colitis: A longitudinal study [J].
Bitton, A ;
Sewitch, MJ ;
Peppercorn, MA ;
Edwardes, MDD ;
Shah, S .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (10) :2203-2208
[9]   Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study [J].
Bonaz, B. ;
Sinniger, V. ;
Hoffmann, D. ;
Clarencon, D. ;
Mathieu, N. ;
Dantzer, C. ;
Vercueil, L. ;
Picq, C. ;
Trocme, C. ;
Faure, P. ;
Cracowski, J-L. ;
Pellissier, S. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 (06) :948-953
[10]   Perceptual responses in patients with inflammatory and functional bowel disease [J].
Chang, L ;
Munakata, J ;
Mayer, EA ;
Schmulson, MJ ;
Johnson, TD ;
Bernstein, CN ;
Saba, L ;
Naliboff, B ;
Anton, PA ;
Matin, K .
GUT, 2000, 47 (04) :497-505